Clinical Trial

Dietary Intervention and Physical Activity in Patients With Heart Failure and Reduced Ejection Fraction

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 19, 2026 (before its estimated July 31, 2026 completion). Its status may not reflect the trial's current state.
Summary
Heart failure with reduced ejection fraction (HFrEF) is frequently associated with abnormalities in body composition, including reduced skeletal muscle mass and sarcopenia, which are independent predictors of reduced exercise tolerance, impaired quality of life, and increased mortality. Despite advances in pharmacological therapy, evidence-based non-pharmacological strategies aimed at preventing muscle mass loss remain limited. This randomized controlled trial aims to evaluate the effects of dietary intervention based on the DASH diet with high-protein elements, resistance exercise training, and their combination on skeletal muscle mass, functional capacity, echocardiographic parameters, biochemical markers, and quality of life in patients with HFrEF.
Trial Details
NCT Number NCT07595809
Lead Sponsor Medical University of Silesia
Conditions Heart Failure With Reduced Ejection Fraction
Enrollment 100 participants
Start Date 2023-05-08
Primary Completion 2026-07-31 (estimated)
Study Completion 2027-04 (estimated)
Updated on ClinicalTrials.gov 2026-05-19